Skip to main content
. 2020 Jun 15;26:e922244-1–e922244-8. doi: 10.12659/MSM.922244

Table 2.

Comparison of patient characteristics between the 2 groups.

Variables <6-cycle (N=29) ≥6-cycle (N=29) P-value
Sex 1.000
 Male 26 26
 Female 3 3
Age
 >60 7 3 0.164
 ≤60 22 26
Karnofsky performance status 0.487
 >80 23 25
 ≤80 6 4
T stage 0.089
 T1–2 6 12
 T3–4 23 17
N stage 0.487
 N0–1 4 6
 N2–3 25 23
Histology (WHO) 1.000
 Type I/II 9 9
 Type III 20 20
Number of bone metastatic sites 1.000
 >3 16 16
 ≤3 13 13
Nasopharyngeal radiotherapy 0.063
 Yes 13 20
 No 16 9